Evidence of intratumoral stem cells in breast cancer patients with BRCA germline mutation

被引：0
作者：
Singer, C. F. [1 ]
Zabkova, P. [1 ]
Pfeiler, G. [1 ]
Gschwantler-Kaulich, D. [1 ]
Fink-Retter, A. [1 ]
Staudigl, C. [1 ]
Walter, I [2 ]
Hudelist, G. [1 ,3 ]
Spiess, A. C. [1 ]
Kubista, E. [1 ]
机构：
[1] Med Univ Wien, Abt Spezielle Gynakol, Vienna, Austria
[2] Vet Med Univ Wien, Abt Histol & Embryiol, Vienna, Austria
[3] LKH Villach, Geburtshilfe & Gynakol Abt, Villach, Austria
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2009年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：761 / 761
页数：1
相关论文
共 50 条
  • [41] Breast reconstruction in patients with BRCA mutation and breast cancer - our approach
    Ventruba, T.
    Brancikova, D.
    Ventruba, P.
    Minar, L.
    Felsinger, M.
    Vomela, J.
    CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY, 2021, 86 (06): : 374 - 380
  • [42] BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil
    Mazzonetto, Patricia
    Milanezi, Fernanda
    D'Andrea, Mariana
    Martins, Silvia
    Monfredini, Priscilla M.
    Silva, Juliana dos Santos
    Perrone, Eduardo
    Villela, Darine
    Schnabel, Beatriz
    Nakano, Viviane
    Palmero, Edenir Inez
    Braggio, Esteban
    Cavalcanti, Thereza L.
    Guida, Gustavo
    Migliavacca, Michele P.
    Scapulatempo-Neto, Cristovam
    Zalcberg, Ilana
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 199 (01) : 127 - 136
  • [43] BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil
    Patricia Mazzonetto
    Fernanda Milanezi
    Mariana D’Andrea
    Silvia Martins
    Priscilla M. Monfredini
    Juliana dos Santos Silva
    Eduardo Perrone
    Darine Villela
    Beatriz Schnabel
    Viviane Nakano
    Edenir Inez Palmero
    Esteban Braggio
    Thereza L. Cavalcanti
    Gustavo Guida
    Michele P. Migliavacca
    Cristovam Scapulatempo-Neto
    Ilana Zalcberg
    Breast Cancer Research and Treatment, 2023, 199 : 127 - 136
  • [44] Efficacy of olaparib monotherapy in patients (pts) with HER2-negative metastatic breast cancer (MBC) with germline BRCA mutation (gBRCAm) or lesional BRCA mutation (lBRCAm).
    Meisner, Eleanor
    Rollins, Rebecca
    Ensor, Joe
    Moran, Amber
    Woodward, Amanda
    Ahn, Eugene R.
    Lynch, Cynthia Anne
    Citrin, Dennis L.
    Hansra, Damien
    Aithal, Sramila S.
    Ninan, Mary
    Nixon, Daniel W.
    Zook, Susan
    Ali, Siraj Mahamed
    Markman, Maurie
    Alvarez, Ricardo H.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] Awareness and Availability of Routine Germline BRCA1/2 Mutation Testing in Patients with Advanced Breast Cancer in Germany
    Lux, Michael P.
    Decker, Thomas
    Runkel, Eva Diana
    Niyazov, Alexander
    Quek, Ruben G. W.
    Marschner, Norbert
    Harbeck, Nadia
    BREAST CARE, 2022, 17 (01) : 40 - 46
  • [46] BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families
    K Claes
    B Poppe
    I Coene
    A De Paepe
    L Messiaen
    British Journal of Cancer, 2004, 90 : 1244 - 1251
  • [47] Adjuvant olaparib - High risk early breast cancer with BRCA1 or BRCA2 germline mutation
    Bonneau, Maeva
    Bellesoeur, Audrey
    BULLETIN DU CANCER, 2023, 110 (11) : 1092 - 1093
  • [48] Germline mutation analysis of BRCA1 and BRCA2 genes in Yugoslav breast/ovarian cancer families
    Papp, J
    Raicevic, L
    Milasin, J
    Dimitrijevic, B
    Radulovic, S
    Olah, E
    ONCOLOGY REPORTS, 1999, 6 (06) : 1435 - 1438
  • [49] BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families
    Claes, K
    Poppe, B
    Coene, I
    De Paepe, A
    Messiaen, L
    BRITISH JOURNAL OF CANCER, 2004, 90 (06) : 1244 - 1251
  • [50] Response to Olaparib in a Patient with Germline BRCA2 Mutation and Breast Cancer Leptomeningeal Carcinomatosis
    Pedro Exman
    Robert M. Mallery
    Nancy U. Lin
    Heather A. Parsons
    npj Breast Cancer, 5
12345